Siblings 會議論文/會議摘要 [27/39] 專利 [0/32] Collection Statistics 近3年內發表的文件:8(5.56%) 含全文筆數:143(99.31%) 文件下載次數統計 下載大於0次:143(100.00%) 下載大於100次:141(98.60%) 檔案下載總次數:87248(84.49%) 最後更新時間: 2024-12-01 01:23 Top Upload Loading... Top Download Loading... Recent Submissions Development of a humanized antibody... Reducing brain Abeta burden amelior... Development of furanopyrimidine-bas... Targeting the phosphatidylserine-im... Synthesis and evaluation of small m... Extracellular HSP90alpha induces My... The beneficial effects of combining... Acyl-coenzyme a synthetase long-cha... Colloidal assemblies composed of po... The effects of Abeta1-42 binding to...

Jump to a point in the index: (Choose year) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (Choose month) January February March April May June July August September October November December Or type in a year:

Ordering With Most Recent First Show Oldest First

Showing items 51-60 of 144. (15 Page(s) Totally) << < 1 2 3 4 5 6 7 8 9 10 > >> View [10|25|50] records per page

Date	Title	Relation
2014-05	Cover Picture: Facile identification of dual FLT3–aurora a inhibitors: A computer-guided drug design approach (ChemMedChem 5/2014)	ChemMedChem. 2014 May;9(5):861.
2014-02	Epstein-Barr virus BALF3 has nuclease activity and mediates mature virion production during the lytic cycle	Journal of Virology. 2014 Feb;88(9):4962-4975.
2014-01-08	Evaluation of the antitumor effects of BPR1J-340, a potent and selective FLT3 inhibitor, alone or in combination with an HDAC inhibitor, vorinostat, in AML cancer	PLoS ONE. 2014 Jan 8;9(1):Article number e83160.
2013-12	Evolutionarily conserved residues at an oligomerization interface of the influenza A virus neuraminidase are essential for viral survival	Virology. 2013 Dec;447(1-3):32-44.
2013-09-22	A novel Aurora-A inhibitor, BPR1K0609S1, sensitizes colorectal tumor cells to 5-fluorofracil (5-FU) treatment [Erratum:International Journal of Biological Sciences. 2013 Apr 29;9(4):403-411]	International Journal of Biological Sciences. 2013 Sep 22;9(9):947.
2013-06-28	Optimization of ligand and lipophilic efficiency to identify an in vivo active furano-pyrimidine aurora kinase inhibitor	Journal of Medicinal Chemistry. 2013 Jun 28;56(13):5247-5260.
2013-06	Discovery of 3-phenyl-1H-5-pyrazolylamine derivatives containing a urea pharmacophore as potent and efficacious inhibitors of FMS-like tyrosine kinase-3 (FLT3)	Bioorganic and Medicinal Chemistry. 2013 Jun;21(11):2856-2867.
2013-06	Synthesis of acylguanidine zanamivir derivatives as neuraminidase inhibitors and the evaluation of their bio-activities	Organic and Biomolecular Chemistry. 2013 Jun;11(24):3943-3948.
2013-05	Aurora kinase inhibitors reveal mechanisms of HURP in nucleation of centrosomal and kinetochore microtubules	Proceedings of the National Academy of Sciences of the United States of America. 2013 May;110(19):E1779-E1787.
2013-05	Protein kinase inhibitor design by targeting the Asp-Phe-Gly (DFG) motif: The role of the DFG motif in the design of epidermal growth factor receptor inhibitors	Journal of Medicinal Chemistry. 2013 May;56(10):3889-3903.

Showing items 51-60 of 144. (15 Page(s) Totally) << < 1 2 3 4 5 6 7 8 9 10 > >> View [10|25|50] records per page